Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Indian Dermatol Online J ; 4(2): 122-4, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23741671

ABSTRACT

We report a case of severe Morbihan syndrome (chronic erythematous edema of the upper portion of the face) in a 60-year-old man. The syndrome was characterized clinically by erythematous edema involving the forehead, glabella, and both eyelids, because of which the patient was not able to open completely his eyes. Furthermore, erythema and telangiectasiae were visible on the nose and cheeks. Laboratory and instrumental examinations were within normal ranges or negative. Histopathological examination showed dermal edema, perivascular and periadnexal lympho-histiocytic infiltrate, and sebaceous gland hyperplasia. Oral isotretinoin was ineffective despite the relatively long duration of the therapy (26 weeks).

2.
Int J Dermatol ; 52(3): 327-30, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23414157

ABSTRACT

BACKGROUND: Hookworm-related cutaneous larva migrans (CLM) is characterized clinically by erythematous and slightly raised tracks, located especially on the feet. These tracks may be single or multiple, linear or serpiginous, more or less ramified and intertwined. The length is variable (up to many cm); the width ranges from 1 mm to 4 mm. Tracks are often accompanied by severe pruritus. METHODS: Three adult Caucasian patients recently returned from trips to Malaysia and Thailand, presented with follicular CLM. The disease was characterized clinically by follicular, erythematous, small papules that were sometimes topped with vesicles or pustules, located on the buttocks. Pruritus was severe. RESULTS: Histopathological examinations revealed a perifollicular infiltrate predominantly consisting of lymphocytes and eosinophils. All patients were successfully treated with oral albendazole (400 mg/day for seven days). In the first patient, two courses were necessary. CONCLUSIONS: Dermatologists should be aware of the existence of this rare and atypical, although emerging, clinical presentation of hookworm-related CLM.


Subject(s)
Larva Migrans/diagnosis , Travel , Adult , Albendazole/therapeutic use , Ancylostomatoidea/isolation & purification , Animals , Anthelmintics/therapeutic use , Female , Humans , Larva Migrans/drug therapy , Malaysia , Male , Pruritus/diagnosis , Pruritus/drug therapy , Thailand
3.
Int J Infect Dis ; 17(4): e277-9, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23218549

ABSTRACT

OBJECTIVES: The purpose of this study is to present the 'chronic' or 'persistent' form of hookworm-related cutaneous larva migrans. METHODS: From 1998 to 2011, 13 patients were seen in our department with clinically typical hookworm-related cutaneous larva migrans that had been present for more than 5 months and that, because of the absence of pruritus, had never been treated. RESULTS: The duration of hookworm-related cutaneous larva migrans ranged from 5 to 14 months (mean 7.8 months) in these 13 patients (10 males and three females, aged 23-55 years). The infestation was acquired in Brazil (three patients), Jamaica (three patients), Mexico (two patients), Tanzania (two patients), Thailand (two patients), and Martinique (one patient). The infestation was located on the feet in 10 patients; one of these patients also presented tracks on the back and another presented tracks on a knee. The chest (two patients) and thigh (two patients) were also involved. All patients presented with clinically typical hookworm-related cutaneous larva migrans: seven patients had one track and six patients had two tracks. Laboratory and instrumental examinations were within the normal range or negative. Histopathological examination revealed edema in the papillary and upper dermis, and a perivascular and perifollicular infiltrate in the upper dermis, consisting mainly of lymphocytes and eosinophils. No larvae were detected. CONCLUSIONS: This can be considered the 'chronic' or 'persistent' form of hookworm-related cutaneous larva migrans. Some pathogenetic hypotheses are suggested.


Subject(s)
Hookworm Infections/pathology , Larva Migrans/pathology , Pruritus/pathology , Adult , Ancylostomatoidea/growth & development , Animals , Brazil , Chronic Disease , Female , Hookworm Infections/parasitology , Humans , Larva/growth & development , Larva Migrans/parasitology , Male , Middle Aged , Pruritus/parasitology , Time Factors , Young Adult
4.
J Drugs Dermatol ; 11(11): e70-3, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23135097

ABSTRACT

BACKGROUND AND OBJECTIVE: Many tinea inguinalis infections are characterized by pronounced inflammatory lesions and pruritus. Therefore, a therapy with a topical corticosteroid in addition to a topical antimycotic agent might be beneficial. In this multicenter, retrospective study, we compared the mycological and clinical efficacy and tolerability of isoconazole nitrate alone vs isoconazole nitrate and diflucortolone valerate in 58 adult patients with tinea inguinalis. PATIENTS AND METHODS: Treatment duration was three weeks. The efficacy of the treatment was based on the assessment of several signs and symptoms, which were collected on a 4-point scale. All patients were examined clinically before the beginning of the treatment, one week later, two weeks later, and at the end of the treatment. Mycological examinations were performed before the beginning of the treatment and at the end of the study. RESULTS: Treatment results with the combination of isoconazole nitrate and diflucortolone valerate were superior regarding erythema and pruritus. Both erythema and pruritus resolved in a larger percentage of patients and more quickly. Both regimens were well tolerated. Mycological cure rates were similar in both groups of patients. CONCLUSIONS: Combination therapy with isoconazole nitrate and diflucortolone valerate is an effective and well-tolerated regimen in adult patients with tinea inguinalis.


Subject(s)
Antifungal Agents/therapeutic use , Diflucortolone/analogs & derivatives , Miconazole/analogs & derivatives , Tinea/drug therapy , Administration, Cutaneous , Adolescent , Adult , Antifungal Agents/administration & dosage , Antifungal Agents/adverse effects , Diflucortolone/administration & dosage , Diflucortolone/adverse effects , Diflucortolone/therapeutic use , Drug Therapy, Combination , Erythema/drug therapy , Erythema/microbiology , Humans , Male , Miconazole/administration & dosage , Miconazole/adverse effects , Miconazole/therapeutic use , Middle Aged , Pruritus/drug therapy , Pruritus/microbiology , Retrospective Studies , Time Factors , Tinea/microbiology , Treatment Outcome , Young Adult
5.
J Dermatolog Treat ; 23(3): 189-91, 2012 Jun.
Article in English | MEDLINE | ID: mdl-21294643

ABSTRACT

We evaluated retrospectively the efficacy and tolerability of oral albendazole (400 mg/day for 1 week) in 78 patients with hookworm-related cutaneous larva migrans characterized by multiple and/or extensive lesions. The diagnosis was based on history and the clinical picture. Neither topical or systemic drugs nor physical treatments were used. All patients were followed-up for at least 3 months after the therapy. All patients were cured at the end of the therapy. The disappearance of pruritus was reported after 2-3 days and skin lesions after 5-7 days of therapy. One patient reported nausea and abdominal pain; another patient reported worsening of pruritus: in both cases it was not necessary to stop the therapy. No recurrences were observed during follow-up. One week of therapy with 400 mg/day oral albendazole is very effective (cure rate: 100%) in patients with cutaneous larva migrans characterized by multiple and/or extensive lesions. This therapeutical regimen is not accompanied by the appearance of new and/or more severe side effects.


Subject(s)
Albendazole/administration & dosage , Anthelmintics/administration & dosage , Larva Migrans/drug therapy , Pruritus/drug therapy , Administration, Oral , Adolescent , Adult , Aged , Albendazole/adverse effects , Anthelmintics/adverse effects , Female , Follow-Up Studies , Humans , Male , Middle Aged , Retrospective Studies , Time Factors , Treatment Outcome , Young Adult
6.
J Am Podiatr Med Assoc ; 101(4): 353-5, 2011.
Article in English | MEDLINE | ID: mdl-21817006

ABSTRACT

Tungiasis is an infestation caused by penetration of the skin by the gravid female of the flea Tunga penetrans Linnaeus 1758 (Insecta, Siphonaptera: Tungidae). Tunga penetrans is currently found in Central and South America, sub-Saharan Africa, and Central Asia. Prevalence is very high in Brazil. We present a case of tungiasis in an Italian beach volleyball player who acquired the infestation in Brazil.


Subject(s)
Foot Dermatoses/parasitology , Travel , Tunga/parasitology , Tungiasis/diagnosis , Adult , Animals , Brazil , Foot Dermatoses/etiology , Humans , Male , Skin Diseases, Parasitic/diagnosis , Skin Diseases, Parasitic/surgery , Tungiasis/surgery , Volleyball
8.
Article in English | MEDLINE | ID: mdl-17656118

ABSTRACT

We report a case of leishmaniasis localized to the upper lip in a 77-year-old Italian man. The disease was characterized by a severe swelling which involved the right side of the upper lip. The swelling was slightly erythematous with crusts and scaling. Consistency was parenchymatous-hard. The lesion was asymptomatic. Histopathologic examination showed an inflammatory infiltrate consisting of lymphocytes, histiocytes, and plasma cells. Several Leishmania spp. amastigotes were observed in the cytoplasm of macrophages. Cultural examination on Novy-MacNeal-Nicolle medium was positive for Leishmania spp. Polymerase chain reaction was positive for Leishmania infantum. The patient was treated with i.m. N-methylglucamine antimonate, with complete remission in approximately 6 weeks. During follow-up of 9 months, no relapses were observed.


Subject(s)
Antiprotozoal Agents/therapeutic use , Leishmaniasis, Cutaneous/pathology , Lip Diseases/pathology , Lip/pathology , Meglumine/therapeutic use , Organometallic Compounds/therapeutic use , Aged , Diagnosis, Differential , Humans , Leishmaniasis, Cutaneous/drug therapy , Lip Diseases/drug therapy , Male , Meglumine Antimoniate
SELECTION OF CITATIONS
SEARCH DETAIL
...